The global market for Phospholipids in Pharmaceutical was estimated to be worth US$ 158 million in 2023 and is forecast to a readjusted size of US$ 271 million by 2030 with a CAGR of 8.4% during the forecast period 2024-2030

Phospholipids in Pharmaceutical - Market

In pharmaceutical formulations, phospholipids obtained from plant or animal sources and synthetic phospholipids are used. Natural phospholipids are purified from, e.g., soybeans or egg yolk using non-toxic solvent extraction and chromatographic procedures with low consumption of energy and minimum possible waste. Because of the use of validated purification procedures and sourcing of raw materials with consistent quality, the resulting products differing in phosphatidylcholine content possess an excellent batch to batch reproducibility with respect to phospholipid and fatty acid composition. The natural phospholipids are described in pharmacopeias and relevant regulatory guidance documentation of the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Synthetic phospholipids with specific polar head group, fatty acid composition can be manufactured using various synthesis routes. Synthetic phospholipids with the natural stereochemical configuration are preferably synthesized from glycerophosphocholine (GPC), which is obtained from natural phospholipids, using acylation and enzyme catalyzed reactions. Synthetic phospholipids play compared to natural phospholipid (including hydrogenated phospholipids), as derived from the number of drug products containing synthetic phospholipids, a minor role. Only in a few pharmaceutical products synthetic phospholipids are used. Natural phospholipids are used in oral, dermal, and parenteral products including liposomes. Natural phospholipids instead of synthetic phospholipids should be selected as phospholipid excipients for formulation development, whenever possible, because natural phospholipids are derived from renewable sources and produced with more ecologically friendly processes and are available in larger scale at relatively low costs compared to synthetic phospholipids.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Phospholipids in Pharmaceutical, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phospholipids in Pharmaceutical by region & country, by Type, and by Application.

The Phospholipids in Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phospholipids in Pharmaceutical.

Market Segmentation

Scope of Phospholipids in Pharmaceutical - Market Report

Report Metric	Details
Report Name	Phospholipids in Pharmaceutical - Market
Forecasted market size in 2030	US$ 271 million
CAGR	8.4%
Forecasted years	2024 - 2030
Segment by Type:	Soy Egg Synthetic Others
Segment by Application	Oral Products Dermal Products Parenteral Products Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cargill, Avril, Croda, Lipoid, Nippon Fine Chemical, Sonic Biochem, Nabros Pharma, Vav, NOF
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phospholipids in Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Phospholipids in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Phospholipids in Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Phospholipids in Pharmaceutical - Market size in 2030?

Ans: The Phospholipids in Pharmaceutical - Market size in 2030 will be US$ 271 million.

Who are the main players in the Phospholipids in Pharmaceutical - Market report?

Ans: The main players in the Phospholipids in Pharmaceutical - Market are Cargill, Avril, Croda, Lipoid, Nippon Fine Chemical, Sonic Biochem, Nabros Pharma, Vav, NOF

What are the Application segmentation covered in the Phospholipids in Pharmaceutical - Market report?

Ans: The Applications covered in the Phospholipids in Pharmaceutical - Market report are Oral Products, Dermal Products, Parenteral Products, Others

What are the Type segmentation covered in the Phospholipids in Pharmaceutical - Market report?

Ans: The Types covered in the Phospholipids in Pharmaceutical - Market report are Soy, Egg, Synthetic, Others

1 Market Overview

1.1 Phospholipids in Pharmaceutical Product Introduction

1.2 Global Phospholipids in Pharmaceutical Market Size Forecast

1.2.1 Global Phospholipids in Pharmaceutical Sales Value (2019-2030)

1.2.2 Global Phospholipids in Pharmaceutical Sales Volume (2019-2030)

1.2.3 Global Phospholipids in Pharmaceutical Sales Price (2019-2030)

1.3 Phospholipids in Pharmaceutical Market Trends & Drivers

1.3.1 Phospholipids in Pharmaceutical Industry Trends

1.3.2 Phospholipids in Pharmaceutical Market Drivers & Opportunity

1.3.3 Phospholipids in Pharmaceutical Market Challenges

1.3.4 Phospholipids in Pharmaceutical Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Phospholipids in Pharmaceutical Players Revenue Ranking (2023)

2.2 Global Phospholipids in Pharmaceutical Revenue by Company (2019-2024)

2.3 Global Phospholipids in Pharmaceutical Players Sales Volume Ranking (2023)

2.4 Global Phospholipids in Pharmaceutical Sales Volume by Company Players (2019-2024)

2.5 Global Phospholipids in Pharmaceutical Average Price by Company (2019-2024)

2.6 Key Manufacturers Phospholipids in Pharmaceutical Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Phospholipids in Pharmaceutical Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Phospholipids in Pharmaceutical

2.9 Phospholipids in Pharmaceutical Market Competitive Analysis

2.9.1 Phospholipids in Pharmaceutical Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Phospholipids in Pharmaceutical Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phospholipids in Pharmaceutical as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Soy

3.1.2 Egg

3.1.3 Synthetic

3.1.4 Others

3.2 Global Phospholipids in Pharmaceutical Sales Value by Type

3.2.1 Global Phospholipids in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Phospholipids in Pharmaceutical Sales Value, by Type (2019-2030)

3.2.3 Global Phospholipids in Pharmaceutical Sales Value, by Type (%) (2019-2030)

3.3 Global Phospholipids in Pharmaceutical Sales Volume by Type

3.3.1 Global Phospholipids in Pharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Phospholipids in Pharmaceutical Sales Volume, by Type (2019-2030)

3.3.3 Global Phospholipids in Pharmaceutical Sales Volume, by Type (%) (2019-2030)

3.4 Global Phospholipids in Pharmaceutical Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oral Products

4.1.2 Dermal Products

4.1.3 Parenteral Products

4.1.4 Others

4.2 Global Phospholipids in Pharmaceutical Sales Value by Application

4.2.1 Global Phospholipids in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Phospholipids in Pharmaceutical Sales Value, by Application (2019-2030)

4.2.3 Global Phospholipids in Pharmaceutical Sales Value, by Application (%) (2019-2030)

4.3 Global Phospholipids in Pharmaceutical Sales Volume by Application

4.3.1 Global Phospholipids in Pharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Phospholipids in Pharmaceutical Sales Volume, by Application (2019-2030)

4.3.3 Global Phospholipids in Pharmaceutical Sales Volume, by Application (%) (2019-2030)

4.4 Global Phospholipids in Pharmaceutical Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Phospholipids in Pharmaceutical Sales Value by Region

5.1.1 Global Phospholipids in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Phospholipids in Pharmaceutical Sales Value by Region (2019-2024)

5.1.3 Global Phospholipids in Pharmaceutical Sales Value by Region (2025-2030)

5.1.4 Global Phospholipids in Pharmaceutical Sales Value by Region (%), (2019-2030)

5.2 Global Phospholipids in Pharmaceutical Sales Volume by Region

5.2.1 Global Phospholipids in Pharmaceutical Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Phospholipids in Pharmaceutical Sales Volume by Region (2019-2024)

5.2.3 Global Phospholipids in Pharmaceutical Sales Volume by Region (2025-2030)

5.2.4 Global Phospholipids in Pharmaceutical Sales Volume by Region (%), (2019-2030)

5.3 Global Phospholipids in Pharmaceutical Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Phospholipids in Pharmaceutical Sales Value, 2019-2030

5.4.2 North America Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Phospholipids in Pharmaceutical Sales Value, 2019-2030

5.5.2 Europe Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Phospholipids in Pharmaceutical Sales Value, 2019-2030

5.6.2 Asia Pacific Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Phospholipids in Pharmaceutical Sales Value, 2019-2030

5.7.2 South America Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Phospholipids in Pharmaceutical Sales Value, 2019-2030

5.8.2 Middle East & Africa Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Phospholipids in Pharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Phospholipids in Pharmaceutical Sales Value

6.2.1 Key Countries/Regions Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.2.2 Key Countries/Regions Phospholipids in Pharmaceutical Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.3.2 United States Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.4.2 Europe Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.5.2 China Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.5.3 China Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.6.2 Japan Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.7.2 South Korea Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.8.2 Southeast Asia Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Phospholipids in Pharmaceutical Sales Value, 2019-2030

6.9.2 India Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

6.9.3 India Phospholipids in Pharmaceutical Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Cargill

7.1.1 Cargill Company Information

7.1.2 Cargill Introduction and Business Overview

7.1.3 Cargill Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Cargill Phospholipids in Pharmaceutical Product Offerings

7.1.5 Cargill Recent Development

7.2 Avril

7.2.1 Avril Company Information

7.2.2 Avril Introduction and Business Overview

7.2.3 Avril Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Avril Phospholipids in Pharmaceutical Product Offerings

7.2.5 Avril Recent Development

7.3 Croda

7.3.1 Croda Company Information

7.3.2 Croda Introduction and Business Overview

7.3.3 Croda Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Croda Phospholipids in Pharmaceutical Product Offerings

7.3.5 Croda Recent Development

7.4 Lipoid

7.4.1 Lipoid Company Information

7.4.2 Lipoid Introduction and Business Overview

7.4.3 Lipoid Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Lipoid Phospholipids in Pharmaceutical Product Offerings

7.4.5 Lipoid Recent Development

7.5 Nippon Fine Chemical

7.5.1 Nippon Fine Chemical Company Information

7.5.2 Nippon Fine Chemical Introduction and Business Overview

7.5.3 Nippon Fine Chemical Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Nippon Fine Chemical Phospholipids in Pharmaceutical Product Offerings

7.5.5 Nippon Fine Chemical Recent Development

7.6 Sonic Biochem

7.6.1 Sonic Biochem Company Information

7.6.2 Sonic Biochem Introduction and Business Overview

7.6.3 Sonic Biochem Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sonic Biochem Phospholipids in Pharmaceutical Product Offerings

7.6.5 Sonic Biochem Recent Development

7.7 Nabros Pharma

7.7.1 Nabros Pharma Company Information

7.7.2 Nabros Pharma Introduction and Business Overview

7.7.3 Nabros Pharma Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Nabros Pharma Phospholipids in Pharmaceutical Product Offerings

7.7.5 Nabros Pharma Recent Development

7.8 Vav

7.8.1 Vav Company Information

7.8.2 Vav Introduction and Business Overview

7.8.3 Vav Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Vav Phospholipids in Pharmaceutical Product Offerings

7.8.5 Vav Recent Development

7.9 NOF

7.9.1 NOF Company Information

7.9.2 NOF Introduction and Business Overview

7.9.3 NOF Phospholipids in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)

7.9.4 NOF Phospholipids in Pharmaceutical Product Offerings

7.9.5 NOF Recent Development

8 Industry Chain Analysis

8.1 Phospholipids in Pharmaceutical Industrial Chain

8.2 Phospholipids in Pharmaceutical Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Phospholipids in Pharmaceutical Sales Model

8.5.2 Sales Channel

8.5.3 Phospholipids in Pharmaceutical Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Phospholipids in Pharmaceutical Market Trends

Table 2. Phospholipids in Pharmaceutical Market Drivers & Opportunity

Table 3. Phospholipids in Pharmaceutical Market Challenges

Table 4. Phospholipids in Pharmaceutical Market Restraints

Table 5. Global Phospholipids in Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Phospholipids in Pharmaceutical Revenue Market Share by Company (2019-2024)

Table 7. Global Phospholipids in Pharmaceutical Sales Volume by Company (2019-2024) & (Tons)

Table 8. Global Phospholipids in Pharmaceutical Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Phospholipids in Pharmaceutical Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Phospholipids in Pharmaceutical Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Phospholipids in Pharmaceutical Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Phospholipids in Pharmaceutical

Table 13. Global Phospholipids in Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phospholipids in Pharmaceutical as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Phospholipids in Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Phospholipids in Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Phospholipids in Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Phospholipids in Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Phospholipids in Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Phospholipids in Pharmaceutical Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)

Table 22. Global Phospholipids in Pharmaceutical Sales Volume by Type (2019-2024) & (Tons)

Table 23. Global Phospholipids in Pharmaceutical Sales Volume by Type (2025-2030) & (Tons)

Table 24. Global Phospholipids in Pharmaceutical Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Phospholipids in Pharmaceutical Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Phospholipids in Pharmaceutical Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Phospholipids in Pharmaceutical Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Phospholipids in Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Phospholipids in Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Phospholipids in Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Phospholipids in Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Phospholipids in Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Phospholipids in Pharmaceutical Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)

Table 34. Global Phospholipids in Pharmaceutical Sales Volume by Application (2019-2024) & (Tons)

Table 35. Global Phospholipids in Pharmaceutical Sales Volume by Application (2025-2030) & (Tons)

Table 36. Global Phospholipids in Pharmaceutical Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Phospholipids in Pharmaceutical Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Phospholipids in Pharmaceutical Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Phospholipids in Pharmaceutical Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Phospholipids in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Phospholipids in Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Phospholipids in Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Phospholipids in Pharmaceutical Sales Value by Region (2019-2024) & (%)

Table 44. Global Phospholipids in Pharmaceutical Sales Value by Region (2025-2030) & (%)

Table 45. Global Phospholipids in Pharmaceutical Sales Volume by Region (Tons): 2019 VS 2023 VS 2030

Table 46. Global Phospholipids in Pharmaceutical Sales Volume by Region (2019-2024) & (Tons)

Table 47. Global Phospholipids in Pharmaceutical Sales Volume by Region (2025-2030) & (Tons)

Table 48. Global Phospholipids in Pharmaceutical Sales Volume by Region (2019-2024) & (%)

Table 49. Global Phospholipids in Pharmaceutical Sales Volume by Region (2025-2030) & (%)

Table 50. Global Phospholipids in Pharmaceutical Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Phospholipids in Pharmaceutical Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Phospholipids in Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Phospholipids in Pharmaceutical Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Phospholipids in Pharmaceutical Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Phospholipids in Pharmaceutical Sales Volume, (2019-2024) & (Tons)

Table 56. Key Countries/Regions Phospholipids in Pharmaceutical Sales Volume, (2025-2030) & (Tons)

Table 57. Cargill Company Information

Table 58. Cargill Introduction and Business Overview

Table 59. Cargill Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Cargill Phospholipids in Pharmaceutical Product Offerings

Table 61. Cargill Recent Development

Table 62. Avril Company Information

Table 63. Avril Introduction and Business Overview

Table 64. Avril Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. Avril Phospholipids in Pharmaceutical Product Offerings

Table 66. Avril Recent Development

Table 67. Croda Company Information

Table 68. Croda Introduction and Business Overview

Table 69. Croda Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Croda Phospholipids in Pharmaceutical Product Offerings

Table 71. Croda Recent Development

Table 72. Lipoid Company Information

Table 73. Lipoid Introduction and Business Overview

Table 74. Lipoid Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Lipoid Phospholipids in Pharmaceutical Product Offerings

Table 76. Lipoid Recent Development

Table 77. Nippon Fine Chemical Company Information

Table 78. Nippon Fine Chemical Introduction and Business Overview

Table 79. Nippon Fine Chemical Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Nippon Fine Chemical Phospholipids in Pharmaceutical Product Offerings

Table 81. Nippon Fine Chemical Recent Development

Table 82. Sonic Biochem Company Information

Table 83. Sonic Biochem Introduction and Business Overview

Table 84. Sonic Biochem Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Sonic Biochem Phospholipids in Pharmaceutical Product Offerings

Table 86. Sonic Biochem Recent Development

Table 87. Nabros Pharma Company Information

Table 88. Nabros Pharma Introduction and Business Overview

Table 89. Nabros Pharma Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Nabros Pharma Phospholipids in Pharmaceutical Product Offerings

Table 91. Nabros Pharma Recent Development

Table 92. Vav Company Information

Table 93. Vav Introduction and Business Overview

Table 94. Vav Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Vav Phospholipids in Pharmaceutical Product Offerings

Table 96. Vav Recent Development

Table 97. NOF Company Information

Table 98. NOF Introduction and Business Overview

Table 99. NOF Phospholipids in Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. NOF Phospholipids in Pharmaceutical Product Offerings

Table 101. NOF Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Phospholipids in Pharmaceutical Downstream Customers

Table 105. Phospholipids in Pharmaceutical Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Phospholipids in Pharmaceutical Product Picture

Figure 2. Global Phospholipids in Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Phospholipids in Pharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Phospholipids in Pharmaceutical Sales Volume (2019-2030) & (Tons)

Figure 5. Global Phospholipids in Pharmaceutical Sales Price (2019-2030) & (US$/Ton)

Figure 6. Phospholipids in Pharmaceutical Report Years Considered

Figure 7. Global Phospholipids in Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Phospholipids in Pharmaceutical Players Sales Volume Ranking (2023) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Phospholipids in Pharmaceutical Revenue in 2023

Figure 10. Phospholipids in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Soy Picture

Figure 12. Egg Picture

Figure 13. Synthetic Picture

Figure 14. Others Picture

Figure 15. Global Phospholipids in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Phospholipids in Pharmaceutical Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Phospholipids in Pharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)

Figure 18. Global Phospholipids in Pharmaceutical Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Phospholipids in Pharmaceutical Price by Type (2019-2030) & (US$/Ton)

Figure 20. Product Picture of Oral Products

Figure 21. Product Picture of Dermal Products

Figure 22. Product Picture of Parenteral Products

Figure 23. Product Picture of Others

Figure 24. Global Phospholipids in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Phospholipids in Pharmaceutical Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Phospholipids in Pharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)

Figure 27. Global Phospholipids in Pharmaceutical Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Phospholipids in Pharmaceutical Price by Application (2019-2030) & (US$/Ton)

Figure 29. North America Phospholipids in Pharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Phospholipids in Pharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Phospholipids in Pharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Phospholipids in Pharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Phospholipids in Pharmaceutical Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Phospholipids in Pharmaceutical Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Phospholipids in Pharmaceutical Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Phospholipids in Pharmaceutical Sales Volume (%), (2019-2030)

Figure 41. United States Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 47. China Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 49. China Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 59. India Phospholipids in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Phospholipids in Pharmaceutical Sales Value by Type (%), 2023 VS 2030

Figure 61. India Phospholipids in Pharmaceutical Sales Value by Application (%), 2023 VS 2030

Figure 62. Phospholipids in Pharmaceutical Industrial Chain

Figure 63. Phospholipids in Pharmaceutical Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions